Global Next-Generation Sequencing Services Market by Service Type (Single Cell Seq, Small RNA Seq) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Industry Insights

Global next-generation sequencing (NGS services) market was valued at USD 1.04 Billion in 2017. It is expected to grow at 13.6% CAGR during the forecast period. The next-generation sequencing technology can be used for both non-conventional and conventional applications. It provides rapid and complete insights at the genomic level. This is due to constant improvements in automation, ancillary protocol, services and analytical solutions in this area. These improvements have led to healthy growth prospects for NGS implementation in clinical workflows.

New seq-technologies have been created to meet the growing demand for reliable sequencing-based diagnostics. These range from portable units to high-throughput sequencers. Recent developments in clinical NGS have been fueled by this trend. ARUP Laboratories, IDbyDNA, Inc., and IDbyDNA, Inc., introduced Explify Respiratory, a NGS test for respiratory infection, in March 2018. This was to help physicians screen patients with pneumonia and other respiratory conditions.

Illumina, the market leader in the field, launched the Illumina Propel Certification Program to create a partnership with laboratories. GENEWIZ, Inc. was awarded Illumina's CSPro NGS certification in December 2013. It also became a member the elite group Illumina genomics service provider. Personalis was another provider to receive the CSPro Certifications back in May 2013.

Many service providers use platforms from Illumina and PacBio as well as Oxford Nanopore Technologies. These technologies are used in-house by service providers to deliver projects on time and with high quality. Some products are not commercially available. These include products from 454 Life Sciences.

Some products, like the SOLiD platform or Ion Torrent's silicon sequencing, are still in development. These products aren't as well-received as Illumina's. Illumina's flagship NovaSeq® 6000 product was launched in March 2017. It can generate 3 to 48 human genomes per run.

Genome sequencing data is a powerful diagnostic and prognostic tool that aids clinicians in identifying the specific characteristics of each patient. This allows for personalized treatments to be offered to patients and improves patient outcomes. This will drive demand for NGS-based diagnostics over the next few years.

End users face major challenges in the NGS service market. These include large-scale data analysis, analytical challenges and single-cell seq. Manufacturers are still strategizing their R&D to address these issues and expand the range of NGS services.

Service Type Insights

NGS-based human genome sequence is the most popular segment. It also holds the largest market share in terms of revenue. Its large share of the market in 2017 was due to the presence of many key players in this sector. This segment includes Veritas Genetics and Veritas Genetics.

Illumina announced in January 2017 that it would launch a new platform for whole-genome sequencing at USD 100. These market leaders are expected to significantly drive segment growth.

Gene regulation services, on the other hand are expected to show a profitable CAGR over the forecast period. This includes small RNA sequencing and ChIP sequencing. It also covers isoform sequencing and bisulfite sequences. RNA sequencing has many advantages that have allowed the replacement of microarrays for many applications. Segment growth will accelerate as a result of the rapid expansion of RNA-seq.

Workflow insights

NGS services are available on the market and include everything from consultation to final result derivation. While some companies provide a complete protocol, others offer standalone services to customers who have NGS facilities in their lab and want to outsource a portion of the NGS workflow.

Due to the high price of instruments, sequencing services held the largest share of the next-generation sequencing market revenue. A wide range of sample types have been offered by companies. Novogene Corporation, for example, conducts sequencing and produces publication-ready data to support customers' research programs in a variety of domains, including agricultural, biomedical and environmental sciences.

Researchers who are involved in sequencing protocols for their projects face many challenges when analysing NGS data. It is essential to have a well-planned and intelligent method for the efficient processing and interpretation data. The demand for data management solutions that are robust is expected to grow as a result of the increase in sequenced reads per cycle.

End-use Insights

Due to the fact that NGS is currently being used primarily for research purposes, universities and other research entities can be considered major end users of this market. To improve their research projects and gain deeper insights into disease mechanisms, sequencing services are being used by research entities.

Hospitals and clinics will see the greatest growth due to the growing trend of clinical NGS. The growing use of NGS technology in clinical settings for the detection and treatment of fetal aneuploidies is reflected in the increasing adoption of NGS technology in prenatal diagnostic procedures.

The liquid biopsy NGS panel, which is being used in cancer management, is also receiving a lot of attention from healthcare providers, including hospitals and clinics. Promising growth will be supported by the establishment of a regulatory framework that allows for NGS to be used in clinical settings.

Regional Insights

North America was the dominant market due to its strong informatics network, regulatory guidelines that allow for approval and use of genetic tests, as well as the presence of leading market players in the region. The market will be driven by the increasing number of FDA-approved genome tests in the U.S. during the forecast period.

Through 2025, the Asia Pacific market will be a profitable source of revenue. Seq-services will be more popular in Asia Pacific due to the increasing attention paid by governments to the maintenance and improvement of public health.

In Asia, there are many domestic players that work together to form mutually beneficial partnerships with international companies. Novogene China partnered with AITbiotech Singapore in 2017 to create NovogeneAIT Genomics Singapore Pte Ltd. Designed to offer sequencing services in Southeast Asia, the company is based in Singapore.

Market Share insights on Next-Generation Sequencing Services

Illumina, Inc., Veritas Genetics, BGI; GENEWIZ Germany GmbH, ABM Inc., ARUP Laboratories, Novogene Corporation, Lucigen, Quest Diagnostics, and Gene by Gene are some of the major players in this market.

They have teamed up with many platform manufacturers to obtain a license for NGS use at their centers. Manufacturers are also pursuing various marketing strategies in order to tap into untapped markets like India, Brazil, China, and China.

Illumina's BaseSpace Sequence Hub was launched in China in January 2018. This hub is a cloud-based platform that allows for the storage, management, interpretation, and analysis of genomic data. This will allow for faster start-ups and improve existing operations in terms sequencing volume and efficiency.

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the global, regional and country level and analyzes the most recent industry trends in each sub-segment from 2014 through 2025. Grand View Research divided the global market for next-generation sequencing services on the basis of type of service, workflow, end user, and location.

• Service Type Outlook (Revenue USD Million, 2014-2025)

  • Human Genome Sequencing

  • Single-cell Sequencing

  • Microbial Genome-based Sequencing

  • Gene Regulation Services

    • Sequencing of small RNA

    • ChIP Sequencing

    • Other Gene Regulation-based Services

  • Animal & Plant Sequencing

  • Other Sequencing Services

• Outlook for Workflow (Revenue, USD million, 2014-2025)

  • Pre-sequencing

  • Sequencing

  • Data Analysis

• End-use Outlook (Revenue USD Million, 2014-2025)

  • Universities & Other Research Entities

  • Hospitals & Clinics

  • Pharma & Biotech Entities

  • Other

• Regional Outlook (Revenue USD Million, 2014-2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

  • Middle East & Africa

    • South Africa

Up Market Research published a new report titled “Next-Generation Sequencing Services Market research report which is segmented by Service Type (Single Cell Seq, Small RNA Seq), By Players/Companies ranging from consultation to final result derivation Some companies offer thorough protocol while others are engaged in offering standalone services to customers that have a lab equipped with NGS facilities but seek to outsource some portions of NGS workflow, various aspects of sequencing”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Next-Generation Sequencing Services Market Report Segments:

The market is segmented by Service Type (Single Cell Seq, Small RNA Seq).

Next-Generation Sequencing Services Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Next-Generation Sequencing Services Market

Overview of the regional outlook of the Next-Generation Sequencing Services Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Next-Generation Sequencing Services Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Next-Generation Sequencing Services Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Single Cell Seq

                2. Small RNA Seq

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Next-Generation Sequencing Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Next-Generation Sequencing Services Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.